Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Section Content Menu
Skip to Common Links
U.S. Food & Drug Administration
A to Z Index
Follow FDA
FDA Voice Blog
Enter Search terms
Most Popular Searches
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
About FDA
Home
About FDA
FDA Organization
Office of Global Regulatory Operations and Policy
Section Contents Menu
FDA Organization
Office of Global Regulatory Operations and Policy
About the Office of Regulatory Affairs
ORA FOIA Electronic Reading Room
-
Eli Lilly and Company, Indianapolis, IN. Inspection January 29 to February 23, 2001, Warning Letter, FDA 483 and responses from firm:
-
FDA 483, dated 02/23/2001; (25 pages)
(PDF - 4.2MB)
Warning Letter, dated 03/02/2001; (3 pages)
(PDF - 383KB)
Response (interim) dated 03/08/2001; (2 pages)
(PDF - 226KB)
Response to FDA dated 03/08/2001; (54 pages)
(PDF - 8.9MB)
-
-
-